Menu
GeneBe

rs104893691

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Moderate

The NM_000388.4(CASR):c.346G>A(p.Ala116Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A116G) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

CASR
NM_000388.4 missense

Scores

6
5
3

Clinical Significance

Likely pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 8.14
Variant links:
Genes affected
CASR (HGNC:1514): (calcium sensing receptor) The protein encoded by this gene is a plasma membrane G protein-coupled receptor that senses small changes in circulating calcium concentration. The encoded protein couples this information to intracellular signaling pathways that modify parathyroid hormone secretion or renal cation handling, and thus this protein plays an essential role in maintaining mineral ion homeostasis. Mutations in this gene are a cause of familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_000388.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-122257241-G-C is described in Lovd as [Pathogenic].
PP2
Missense variant where missense usually causes diseases, CASR
PP3
MetaRNN computational evidence supports a deleterious effect, 0.847
PP5
Variant 3-122257241-G-A is Pathogenic according to our data. Variant chr3-122257241-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 8321.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-122257241-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CASRNM_000388.4 linkuse as main transcriptc.346G>A p.Ala116Thr missense_variant 3/7 ENST00000639785.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CASRENST00000639785.2 linkuse as main transcriptc.346G>A p.Ala116Thr missense_variant 3/71 NM_000388.4 P1P41180-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autosomal dominant hypocalcemia 1 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMMay 01, 1996- -
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 08, 2018DNA sequence analysis of the CASR gene demonstrated a sequence change, c.346G>A, in exon 3 that results in an amino acid change, p.Ala116Thr. The p.Ala116Thr change affects a highly conserved amino acid residue located in a domain of the CASR protein that is known to be functional. The p.Ala116Thr substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This particular sequence change has been previously described as a de novo variant in one family with autosomal dominant hypocalcemia (PMID: 8733126). Affected members had low serum parathyroid hormone (PTH) and low serum calcium concentrations and presented with muscle cramps. Despite low serum calcium concentrations, affected members had significant hypercalciuria that was suggestive of the p.Ala116Thr being an activating mutation (PMID: 8733126). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Pathogenic
0.36
D
BayesDel_noAF
Pathogenic
0.27
Cadd
Uncertain
23
Dann
Uncertain
1.0
DEOGEN2
Benign
0.32
T;T;.;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Uncertain
0.21
D
MetaRNN
Pathogenic
0.85
D;D;D;D
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Benign
0.63
N;N;N;.
MutationTaster
Benign
1.0
A;A;A
PrimateAI
Pathogenic
0.89
D
Polyphen
0.99
D;D;.;.
Vest4
0.89, 0.88
MutPred
0.74
Gain of ubiquitination at K119 (P = 0.0654);Gain of ubiquitination at K119 (P = 0.0654);Gain of ubiquitination at K119 (P = 0.0654);Gain of ubiquitination at K119 (P = 0.0654);
MVP
0.98
MPC
1.6
ClinPred
0.83
D
GERP RS
5.8
Varity_R
0.67
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104893691; hg19: chr3-121976088; API